Skip to content

Inspection Record

Serum Institute of India Private Ltd. — FDA 483 Findings

US FDAInspected 2026-01-30Published 2026-10-26 3 findingsDeviation, CAPA, and investigationProcess validationEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Deviation, CAPA, and investigation

Out of Specification Investigation for the Drug Substance is not thoroughly investigated.

2Process validation

Written production and process control procedures are not documented at the time of performance.

3Equipment and facility

Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination of Drug (Bb)(4) Lots.

Similar findings at other companies

GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.

A record as of the US FDA document published on 2026-10-26. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

Other records for this company

Serum Institute of India Private Ltd. findings history — including this company's other documentsAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.